Condition: Colic · Healthy Infants · Eczema Atopic Dermatitis · Sponsor: Universitair Ziekenhuis Brussel
This study aims to demonstrate that a dietary supplement, which contains two strains of the probiotic L. reuteri is safe, well tolerated and able to reduce the incidence of colic and excessive crying/fussiness in healthy infants. Additionally, the study aims to investigate if children with this probiotic supplement have better stool characteristics and a more beneficial composition of the fecal and skin flora than children given a placebo during the first 3 months of life.
This description comes directly from the study's public registry record.
Koen Huysentruyt, Pediatric Gastroenterologist · +32 02/476.37.17 · koen.huysentruyt@uzbrussel.be
Leontien Depoorter, Resident Pediatric Pulmonology · +32 02/801.25.58 · Leontien.Depoorter@uzbrussel.be
Always discuss trial participation with your own doctor first.
| Universitair Ziekenhuis Brussel | Jette, Brussels Capital, Belgium | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07347743